Robbinsville, NJ – (November 14, 2023) The Executive Committee of the Drug, Chemical & Associated Technologies Association (DCAT) is pleased to announce the appointment of Ms. Carol Lee as DCAT’s new Executive Director.

“I am honored to be appointed as DCAT’s new Executive Director,” shares Ms. Lee. “I look forward to working with the volunteers and association staff to serve the member community and ensuring the DCAT organization continues to be the premier association for the global bio/pharmaceutical manufacturing value chain.”

Ms. Lee joined DCAT in January 2022 and served as its Managing Director. In that role, she was responsible for overseeing the organization’s finances, technology, staff, and vendors. During that time, Ms. Lee was also instrumental in shaping new processes and policies to better serve the DCAT membership community.

“I have enjoyed working with Ms. Lee over the past two years and have great confidence that she will continue to advance the mission of the DCAT organization,” shared DCAT Board President Charles Davies of Merck & Co., Inc. “Ms. Lee has always demonstrated her genuine interest in engaging with our Board on several critical and strategic initiatives. Our entire leadership team, as well as the staff, looks forward to working with her.”

Ms. Lee’s appointment follows the retirement of Margaret M. Timony. When asked about her successor, Ms. Timony stated, “Carol and I have worked closely for the past two years. She is thoughtful and engaging and has proven herself to be an incredibly valuable asset to the organization. She will be a terrific Executive Director.”

Ms. Lee was an Assistant Vice President at Merrill Lynch & Co. for several years.  She brings a wealth of knowledge and experience from multiple accounting and program management roles with increasing responsibilities across financial services, healthcare, and accounting industries. She earned her BS degree from Thomas Edison State College, Trenton, New Jersey.

Ms. Lee assumes her new responsibilities as Executive Director effective November 15, 2023.